(lp0
S'Enzon Pharmaceuticals Selling Well Below Likely Future Distributions Seeking Alpha - May 25, 2016 Enzon Pharmaceuticals , formerly a development-stage darling, is now a $17 million market cap cigar-butt, which receives royalties on several drugs.'
p1
aS'Shares in Review: Enzon Pharmaceuticals, Inc.  Baxter Review - 9 hours ago Enzon Pharmaceuticals, Inc.  currently has a Gross Margin  ratio of 0.482521. Robert Novy-Marx has provided investors with insights on finding high-quality value stocks.'
p2
aS"Warning! Enzon Pharmaceuticals Is Definitely Going To $0 Seeking Alpha - Jan 14, 2014 Finance profile for the company! Right off the bat, that doesn't give us a lot of confidence, now does it? Enzon Pharmaceuticals  used to be a research stage biotech firm, focusing on a technology known as PEGylation. PEGylation was used ..."
p3
aS"Enzon Pharmaceuticals Inc : Icahn's Done His Sums Insider Financial - Dec 2, 2016 Enzon Pharmaceuticals Inc  is an interesting one. The company just gained close to 25% on a 13G filing that revealed Carl Icahn has a close to 15% holding, and has held a position since at least July last year."
p4
aS"Legendary Investor Icahn Still Slugging Away With Enzon Pharma Seeking Alpha - Jan 8, 2013 Carl C. Icahn has been the principal beneficial shareholder of Icahn Enterprises L.P.  and has served as Chairman of the board, a director, and an owner of the company's general partner since 1990. Mr. Icahn heads the investment management&nbsp;..."
p5
aS'Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals GuruFocus.com - Dec 2, 2016 Enzon was formerly a research stage biopharmaceutical company known for its Customized PEGylation Linker Technology.'
p6
aS'Enzon Pharmaceuticals Inc  Hooks the Big Fish The Oracle Dispatch - Nov 30, 2016 Enzon Pharmaceuticals Inc  is a penny play that just did something rather confusing for many folks until you know one new fact.'
p7
aS"BRIEF-Enzon Pharmaceuticals enters into standstill agreement with Icahn and ... Reuters - Dec 8, 2016 NEW YORK, March 17 Forty House Democrats, led by the party's top member of the House of Representatives Financial Services committee Maxine Waters, voiced opposition on Friday to a U.S."
p8
aS'Enzon Pharmaceuticals, Inc.  Ex-Dividend Date Scheduled for January 08, 2015 Nasdaq - Jan 7, 2015 Enzon Pharmaceuticals, Inc.  will begin trading ex-dividend on January 08, 2015. A cash dividend payment of $0.1 per share is scheduled to be paid on January 28, 2015.'
p9
aS'Enzon Pharmaceuticals Inc  Still on Royalty-Driven Autopilot HotStocked - May 19, 2015 While resting on old laurels has so far yielded a comfortable, risk-free cash flow for Enzon, it also leaves room for potential drawbacks, as well.'
p10
a.